Beat the Market Like Zacks: NVIDIA, VirTra, Rockwell Medical in Focus

In This Article:

All three most widely followed indexes closed last week in the green. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite advanced 1.3%, 2.6% and 3.3%, respectively. For the tech-heavy Nasdaq, this marked the eighth consecutive winning week.

Stocks did well throughout the week on the back of encouraging inflation numbers and the Fed’s much anticipated rate-hike pause. However, during the latter part of the week, the market pared some of the gains it had made earlier as cautionary comments made by Fed officials started to sink in. The rate-hike cycle might have come to an end as of now, but it is still likely to be resumed at the next Fed FOMC meeting.

In fact, there is a majoritarian view that the central bank would indeed re-embark on its path of policy-tightening from its next meeting. A few officials have suggested that there would be at least another half a percentage point hike before the year ends. They have also warned that although headline inflation is definitively coming down, core inflation is not.

Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.

As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.

Here are some of our key achievements:

Rockwell Medical and VirTra Surge Following Zacks Rank Upgrade

Shares of Rockwell Medical, Inc. RMTI have soared 129.4% (versus the S&P 500’s 8.5% increase) since it was upgraded to a Zacks Rank #2 (Buy) on April 5.

Another stock, VirTra, Inc. VTSI, which was upgraded to a Zacks Rank #1 (Strong Buy) on April 4, has returned 41.9% (versus the S&P 500’s 7.9% increase) since then.

Zacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

This stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally audited track record, with Zacks Rank #1 stocks generating an average annual return of +24.8% since 1988.You can see the complete list of today’s Zacks Rank #1 stocks here >>>

A hypothetical portfolio of Zacks Rank #1 (Strong Buy) stocks returned +2.7% this year (through May 15th) vs. +7.69% for the S&P 500 index.